Investor Overview

Webcast ImageWebcast
Selecta Biosciences, Inc. at Deutsche Bank 42nd Annual Health Care Conference (Live)
May 03, 2017 at 8:00 a.m. ET
Selecta Biosciences, Inc. at Deutsche Bank 42nd Annual Health Care Conference
Wednesday, May 3, 2017 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Selecta Biosciences is a clinical-stage biopharmaceutical company developing targeted immunotherapies and vaccines that are designed to modulate immune responses to treat and prevent disease. Selecta’s proprietary Synthetic Vaccine Particle (SVP™) platform has the potential to create a new paradigm in immunology and may enable a novel approach for selectively targeting the immune system to effectively and safely treat and prevent rare and serious dis... View more »

Recent News
View all press releases »
Investor Presentations
Download DocumentationMar 31, 2017
Selecta April 2017 Investor Presentation
Download DocumentationMar 27, 2017
Selecta Q4 and Year End 2016 Conference Call Presentation
Upcoming Events
May 03, 2017 8:00 a.m. ET
Selecta Biosciences, Inc. at Deutsche Bank 42nd Annual Health Care Conference
remind me days before the event
May 23, 2017 11:00 a.m. ET
Selecta Biosciences, Inc. at UBS Global Healthcare Conference
remind me days before the event
Enter your e-mail address 
View all events »
Stock Quote
NASDAQ GS :  SELB (Common Stock)
$13.10
+ 0.37 (2.91%)
Stock chart for: SELB.O.  Currently trading at $13.10 with a 52 week high of $28.00 and a 52 week low of $10.26.
Data as of Apr 27, 2017 4:00 p.m. ET
Minimum 15 minute delay
Refresh quote
IR Contact
Jason Fredette
Selecta Biosciences
Phone: 1 617 231 8078
E-mail: JFredette@selectabio.com

Data provided by Nasdaq. Minimum 15 minutes delayed.
Back to Top